Maze Therapeutics Inc. (MAZE)
Market Closed
17 Jul, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
28. 12
+0.96
+3.5156%
$
1.69B Market Cap
- P/E Ratio
- Div Yield
335,900 Volume
- Eps
$ 27.16
Previous Close 
Want to track MAZE and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Maze Therapeutics Inc. (MAZE) Statistics
Valuation metrics
Market Cap 1.69B
Enterprise value 1.42B
Trailing P/E (ttm) -10.23
Forward P/E -
PEG ratio 0.01
Price/Sales (ttm) 77.82
Price/Book (mrq) 4.44
Enterprise Value/Revenue 70.94
Enterprise Value/EBITDA -11.87
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 335.16K
Average volume (90 days) 670.54K
Price summary
52-Week low 12.81
52-Week high 53.65
Beta -
50-Day moving average 27.35
200-Day moving average 36.64
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -6.13%
Operating margin -6.7%
Operational effectiveness
Return on assets -0.29%
Return on equity -0.37%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.37
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -2.27
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 6.54
Total debt (mrq) -
Total Debt/Equity (mrq) 0.18
Current ratio (mrq) 17.88%
Book value per share (mrq) 6.34
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
